Standard Chemical & Pharmaceutical Co., Ltd. (TPE:1720)
Taiwan · Delayed Price · Currency is TWD 63.10
+0.10 (0.16%)
Jun 5, 2026, 1:30 PM CST
TPE:1720 Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 11,276 | 10,525 | 11,061 | 11,776 | 10,990 | 7,702 | |
Market Cap Growth | 5.87% | -4.85% | -6.07% | 7.15% | 42.69% | 14.32% |
Enterprise Value | 12,839 | 12,465 | 13,069 | 13,908 | 12,891 | 8,143 |
Last Close Price | 63.10 | 58.90 | 58.92 | 60.45 | 54.19 | 35.95 |
PE Ratio | 11.73 | 11.35 | 12.56 | 14.11 | 13.48 | 10.90 |
Forward PE | - | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 |
PS Ratio | 1.60 | 1.50 | 1.63 | 1.89 | 1.88 | 1.67 |
PB Ratio | 1.24 | 1.13 | 1.23 | 1.45 | 1.48 | 1.13 |
P/TBV Ratio | 1.93 | 1.78 | 1.94 | 2.32 | 2.43 | 1.87 |
P/FCF Ratio | 7.98 | 8.26 | 10.07 | 16.57 | 345.83 | 12.55 |
P/OCF Ratio | 6.04 | 5.96 | 6.53 | 8.81 | 8.95 | 9.31 |
EV/Sales Ratio | 1.83 | 1.78 | 1.93 | 2.23 | 2.20 | 1.77 |
EV/EBITDA Ratio | 7.05 | 7.06 | 7.38 | 8.81 | 9.28 | 7.59 |
EV/EBIT Ratio | 9.27 | 9.15 | 9.36 | 11.04 | 11.53 | 9.29 |
EV/FCF Ratio | 9.09 | 9.78 | 11.90 | 19.57 | 405.65 | 13.27 |
Debt / Equity Ratio | 0.10 | 0.10 | 0.06 | 0.16 | 0.24 | 0.25 |
Debt / EBITDA Ratio | 0.50 | 0.53 | 0.31 | 0.83 | 1.27 | 1.52 |
Debt / FCF Ratio | 0.65 | 0.75 | 0.51 | 1.87 | 56.33 | 2.72 |
Net Debt / Equity Ratio | -0.16 | -0.15 | -0.14 | -0.11 | -0.09 | -0.16 |
Net Debt / EBITDA Ratio | -0.82 | -0.81 | -0.70 | -0.59 | -0.50 | -1.01 |
Net Debt / FCF Ratio | -1.04 | -1.13 | -1.13 | -1.32 | -21.71 | -1.77 |
Asset Turnover | 0.60 | 0.61 | 0.61 | 0.56 | 0.56 | 0.54 |
Inventory Turnover | 2.54 | 2.50 | 2.28 | 2.34 | 2.58 | 2.40 |
Quick Ratio | 1.39 | 1.74 | 1.89 | 1.56 | 1.38 | 1.56 |
Current Ratio | 2.05 | 2.53 | 3.01 | 2.29 | 1.94 | 2.13 |
Return on Equity (ROE) | 14.48% | 13.75% | 15.13% | 14.87% | 16.21% | 14.30% |
Return on Assets (ROA) | 7.39% | 7.42% | 7.80% | 7.11% | 6.64% | 6.39% |
Return on Invested Capital (ROIC) | 14.88% | 14.51% | 14.88% | 14.55% | 14.80% | 14.59% |
Return on Capital Employed (ROCE) | 14.80% | 14.10% | 14.70% | 14.30% | 13.80% | 11.90% |
Earnings Yield | 8.55% | 8.81% | 7.96% | 7.09% | 7.42% | 9.18% |
FCF Yield | 12.53% | 12.10% | 9.93% | 6.04% | 0.29% | 7.97% |
Dividend Yield | 3.17% | 3.40% | 4.75% | 4.47% | 4.61% | 6.95% |
Payout Ratio | 51.88% | 53.94% | 54.80% | 53.51% | 54.79% | 45.51% |
Buyback Yield / Dilution | -0.17% | -0.01% | -0.01% | -0.00% | 0.02% | -0.02% |
Total Shareholder Return | 3.05% | 3.39% | 4.75% | 4.46% | 4.63% | 6.93% |